*ST界龍(600836.SH)擬變更公司名稱及經營範圍
格隆匯8月21日丨*ST界龍(600836.SH)公佈,公司於2020年8月20日召開第九屆第十五次董事會,審議通過了《關於變更公司名稱、經營範圍並修訂的議案》,公司名稱擬由“上海界龍實業集團股份有限公司”變更為“上海易連實業集團股份有限公司”(公司名稱以工商行政管理部門最終核定為準)。
經營範圍新增:“醫院管理,康復輔具適配服務;軟件開發,醫療器械互聯網信息服務;護理機構服務(不含醫療服務),健康諮詢服務(不含診療服務);第一類醫療器械銷售,第二類醫療器械銷售,農副產品銷售,互聯網銷售(除銷售需要許可的商品),供應鏈管理服務,房地產開發經營。”本議案尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.